Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP).
Filetype[PDF-179.37 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013
    Personal Author:
    MacNeil, Jessica R.; Rubin, Lorry; McNamara, Lucy; Briere, Elizabeth C.; Clark, Thomas A.; Cohn, Amanda C.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    Jun 20 2014
    Source:
    MMWR Morb Mortal Wkly Rep. 2014; 63(24):527-530.
    Description:
    During its October 2013 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended use of a third meningococcal conjugate vaccine, MenACWY-CRM (Menveo, Novartis), as an additional option for vaccinating infants aged 2 through 23 mon...
    File Type:
    Filetype[PDF - 146.37 KB]
  2. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older — United States, 2017
    Personal Author:
    Kim, David K.; Riley, Laura E.; Harriman, Kathleen H.; Hunter, Paul; Bridges, Carolyn B.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    Feb 10 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(5):136-138.
    Description:
    In October 2016, the Advisory Committee on Immunization Practices (ACIP) voted to approve the Recommended Adult Immunization Schedule for Adults Aged 19 Years or Older-United States, 2017. The 2017 adult immunization schedule summarizes ACIP recommen...
    File Type:
    Filetype[PDF - 84.42 KB]
  3. Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
    Personal Author:
    Patton, Monica E.; Stephens, David; Moore, Kelly; MacNeil, Jessica R.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    May 19 2017
    Source:
    MMWR Morb Mortal Wkly Rep. 66(19):509-513.
    Description:
    Two serogroup B meningococcal (MenB) vaccines are currently licensed for use in persons aged 10-25 years in the United States. The two vaccines are MenB-FHbp (Trumenba, Pfizer, Inc.) (1) and MenB-4C (Bexsero, GlaxoSmithKline Biologicals, Inc.) (2). I...
    File Type:
    Filetype[PDF - 142.10 KB]
  4. Advisory Committee on Immunization Practices (ACIP) summary report : February 24, 2016, Atlanta, Georgia
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2016 February 24 : Atlanta, GA)
    Published Date:
    6/23/16
    Series:
    ACIP meeting Minutes
    Description:
    Phosphate ester flame retardants are human-made chemicals added to consumer and industrial products for the purpose of reducing flammability.Phosphate ester flame retardants are composed of a group of chemicals with similar properties but slightly di...
    File Type:
    Filetype[PDF - 3.39 MB]
  5. Advisory Committee on Immunization Practices (ACIP) summary report : February 26, 2015, Atlanta, Georgia
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2015 February 26 : Atlanta, GA)
    Published Date:
    5/26/15
    Series:
    ACIP meeting Minutes
    File Type:
    Filetype[PDF - 2.25 MB]